Abiopharma

🔍 Fisher Steven L (Executive)

Company: Mayville Engineering Company, Inc. (MEC)

Report Date: 2026-04-21

Detailed Transactions and Holdings:

• Acquired 5,883 shares of Common Stock (Direct)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | shares_owned_after: 36,365.00 | transaction_form_type: 4
• Acquired 19,532 shares of Common Stock (Direct)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | shares_owned_after: 55,897.00 | transaction_form_type: 4
• Acquired 14,485 shares of Common Stock (Direct)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | shares_owned_after: 70,382.00 | transaction_form_type: 4
• Acquired 10,331 shares of Common Stock (Direct)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | shares_owned_after: 80,713.00 | transaction_form_type: 4
• Sold 5,883 shares of Director Deferred Stock Units (Derivative)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | shares_owned_after: 34,017.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 19,532 shares of Director Deferred Stock Units (Derivative)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | shares_owned_after: 14,485.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 14,485 shares of Director Deferred Stock Units (Derivative)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 10,331 shares of Director Restricted Stock Units (Derivative)
  Date: 2026-04-21 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: The balance includes vested RSUs that were deferred by the reporting person, which settled upon the reporting person's retirement or separation from the company.
• F2: The restricted stock units vested 100% one year from the grant date.